A collaboration between Ontario Power Generation’s (OPG) subsidiary Canadian Nuclear Partners (CNP) and a subsidiary of BWX Technologies, Inc. (BWXT) will make Darlington Nuclear the first large scale commercial nuclear power station worldwide to produce molybdenum-99 (Mo-99). This will help ensure the world’s long term supply of this critical medical isotope, which is used in over 30 million lifesaving diagnostic and medical treatments each year.
Canada
Darlington nuclear to become new source of lifesaving medical isotopes
More Videos
-
Emily Carr painting sold for $50 at barn sale fetches nearly $350K
-
Why Germany is betting on Canadian geothermal energy tech
-
Trudeau attempts to shore up support with GST ‘holiday’
-
Canada’s consul general defends himself against accusations he pushed for $9M NYC condo
-
Canada Post strike leads to 85K passports stuck in the mail
-
Liberals ‘caved’ to NDP demand of GST cuts on essential goods: Singh
You are viewing an Accelerated Mobile Webpage.
View Original Article